Increased expression of ABC transport proteins is associated with ivermectin resistance in the model nematode Caenorhabditis elegans

International Journal for Parasitology

Volumn 39, Issue 2, 2009, Pages 213-220

  James, Catherine E ^a   Davey, Mary W ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

ABC transporters; Caenorhabditis elegans; Drug resistance; Glutathione; Ivermectin; Multidrug resistance associated proteins (MRP); P glycoprotein

Indexed keywords

ALBENDAZOLE; CARRIER PROTEIN; GLUTATHIONE; GLYCOPROTEIN P; IVERMECTIN; LEVAMISOLE; MOXIDECTIN; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PYRANTEL;

DRUG RESISTANCE; GENE EXPRESSION; IVERMECTIN; NEMATODE; PROTEIN;

ANTIVIRAL RESISTANCE; ARTICLE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TREATMENT RESPONSE;

ANIMALS; ANTHELMINTICS; ANTIPARASITIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CAENORHABDITIS ELEGANS; DRUG RESISTANCE; GLUTATHIONE; IVERMECTIN; P-GLYCOPROTEIN;

CAENORHABDITIS ELEGANS; NEMATODA;

EID: 57649087686     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2008.06.009     Document Type: Article

References (58)

1. Benitez A.J., McNair N., and Mead J. Modulation of gene expression of three Cryptosporidium parvum ATP-binding cassette transporters in response to drug treatment. Parasitol. Res. 101 (2007) 1611-1616
2. Beugnet F., Gauthey M., and Kerboeuf D. Partial in vitro reversal of benzimidazole resistance by the free-living stages of Haemonchus contortus with verapamil. Vet. Rec. 141 (1997) 575-576
3. Blackhall W.J., Prichard R.K., and Beech R.N. P-glycoprotein selection in strains of Haemonchus contortus resistant to benzimidazoles. Vet. Parasitol. 152 (2008) 101-107
4. Blackhall W.J., Liu H.Y., Xu M., Prichard R.K., and Beech R.N. Selection at a P-glycoprotein gene in ivermectin- and moxidectin-selected strains of Haemonchus contortus. Mol. Biochem. Parasitol. 95 (1998) 193-201
5. Bourguinat C., Pion S.D.S., Kamgno J., Gardon J., Duke B.O.L., Boussinesq M., and Prichard R.K. Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment. PLOS Negl. Trop. Dis. 1 (2007) e72
6. Brenner S. The genetics of Caenorhabditis elegans. Genetics 77 (1974) 71-94
7. Broeks A., Gerrard B., Allikmets R., Dean M., and Plasterk R.H. Homologues of the human multidrug resistance genes MRP and MDR contribute to heavy metal resistance in the soil nematode Caenorhabditis elegans. EMBO J. 15 (1996) 6132-6143
8. Broeks A., Janssen H.W., Calafat J., and Plasterk R.H. A P-glycoprotein protects Caenorhabditis elegans against natural toxins. EMBO J. 14 (1995) 1858-1866
9. Coles G.C., Rhodes A.C., and Wolstenholme A.J. Rapid selection for ivermectin resistance in Haemonchus contortus. Vet. Parasitol. 129 (2005) 345-347
10. Cook A., Aptel N., Portillo V., Siney E., Sihota R., Holden-Dye L., and Wolstenholme A.J. Caenorhabditis elegans ivermectin receptors regulate locomotor behaviour and are functional orthologues of Haemonchus contortus receptors. Mol. Biochem. Parasitol. 147 (2006) 118-125
11. Crump A., and Otoguro K. Satoshi Omura: in pursiot of nature's bounty. Trends Parasitol. 21 (2005) 126-132
12. Cully D.F., Vassilatis D.K., Liu K.K., Paress P.S., Van der Ploeg L.H., Schaeffer J.M., and Arena J.P. Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature 371 (1994) 707-711
13. Davey R.A., Longhurst T.J., Davey M.W., Belov L., Harvie R.M., Hancox D., and Wheeler H. Drug resistance mechanisms and MRP expression in response to epirubicin treatment in a human leukaemia cell line. Leuk. Res. 19 (1995) 275-282
14. de Lourdes Mottier M., and Prichard R.K. Genetic analysis of a relationship between macrocyclic lactone and benzimidazole anthelmintic selection on Haemonchus contortus. Pharmacogenet. Genomics 18 (2008) 129-140
15. Dent J.A., Davis M.W., and Avery L. avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans. EMBO J. 16 (1997) 5867-5879
16. Dent J.A., Smith M.M., Vassilatis D.K., and Avery L. The genetics of ivermectin resistance in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 97 (2000) 2674-2679
17. Didier A., and Loor F. The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor. Anticancer Drugs 7 (1996) 745-751
18. Efferth T., and Volm M. Reversal of doxorubicin-resistance in sarcoma 180 tumor cells by inhibition of different resistance mechanisms. Cancer Lett. 70 (1993) 197-202
19. Geary T.G. Ivermectin 20 years on: maturation of a wonder drug. Trends Parasitol. 21 (2005) 530-532
20. Geary T.G., and Thompson D.P. Caenorhabditis elegans: how good a model for veterinary parasites?. Vet. Parasitol. 101 (2001) 371-386
21. Gilleard J.S. Understanding anthelmintic resistance: the need for genomics and genetics. Int. J. Parasitol. 36 (2006) 1227-1239
22. Gottesman M.M., Fojo T., and Bates S.E. Multidrug resistance in cancer: role of ATP-dependant transporters. Nat. Rev. Cancer 2 (2002) 48-58
23. Grech K.V., Davey R.A., and Davey M.W. The relationship between modulation of MDR and glutathione in MRP-overexpressing human leukemia cells. Biochem. Pharmacol. 55 (1998) 1283-1289
24. Grondin K., Haimeur A., Mukhopadhyay R., Rosen B.P., and Ouellette M. Co-amplification of the γ-glutamylcysteine synthetase gene gsh-1 and of the ABC transporter gene pgpA in arsenite-resistant Leishmania tarentolae. EMBO J. 16 (1997) 3057-3065
25. Henness S., Davey M.W., Harvie R.M., Banyer J., Wasinger V., Corthals G., and Davey R.A. Changes in gene expression associated with stable drug and radiation resistance in small cell lung cancer cells are similar to those caused by a single X-ray dose. Radiat. Res. 161 (2004) 495-503
26. Ishikawa T., Bao J., Yamane Y., Akimaru K., Frindrich K., Wright C.D., and Kuo M.T. Coordinated induction of MRP/GS-X pump and γ-glytamylcysteine synthetase by heavy metals in human leukemia cells. J. Biol. Chem. 271 (1996) 14981-14988
27. James C.E., and Davey M.W. A rapid colorimetric assay for the quantitation of the viability of free-living larvae of nematodes in vitro. Parasitol. Res. 101 (2007) 975-980
28. Jin W., Scotto K.W., Hait W.N., and Yang J.M. Involvement of CtBP1 in the transcriptional activation of the MDR1 gene in human multidrug resistant cancer cells. Biochem. Pharmacol. 74 (2007) 851-859
29. Kaminsky R., Ducray P., Jung M., Clover R., Rufener L., Bouvier J., Schorderet Weber S., Wenger A., Wieland-Berghausen S., Goebel T., Gauvry N., Pautrat F., Skripsky T., Froelich O., Komoin-Oka C., Westlund B., Sluder A., and Maser P. A new class of anthelmintics effective against drug-resistant nematodes. Nature 452 (2008) 176-180
30. Kantharidis P., El-Osta S., Silva M., Lee G., Hu X.F., and Zalcberg J. Regulation of MDR1 gene expression: emerging concepts. Drug Resist. Update 3 (2000) 99-108
31. Keppler D., Cui Y., Konig J., Leier I., and Nies A. Export pumps for anionic conjugates encoded by MRP genes. Adv. Enzyme Regul. 39 (1999) 237-246
32. Le Jambre L.F., Lenane I.J., and Wardrop A.J. A hybridisation technique to identify anthelmintic resistance genes in Haemonchus. Int. J. Parasitol. 29 (1999) 1979-1985
33. Leslie E.M., Deeley R.G., and Cole S.P. Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology 167 (2001) 3-23
34. Lespine A., Alvinerie M., Vercruysse J., Prichard R.K., and Geldhof P. ABC transporter modulation: a strategy to enhance the activity of macrocyclic lactone anthelmintics. Trends Parasitol. 24 (2008) 293-298
35. Lespine A., Dupuy J., Orlowski S., Nagy T., Glavinas H., Krajcsi P., and Alvinerie M. Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3). Chem. Biol. Interact. 159 (2006) 169-179
36. Lespine A., Martin S., Dupuy J., Roulet A., Pineay T., Orlowski S., and Alvinerie M. Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship. Eur. J. Pharm. Sci. 30 (2007) 84-94
37. Liao V.H., and Yu C.W. Caenorhabditis elegans gcs-1 confers resistance to arsenic-induced oxidative stress. Biometals 18 (2005) 519-528
38. Lincke C.R., Broeks A., The I., Plasterk R.H.A., and Borst P. The expression of two P-glycoprotein (pgp) genes in transgenic Caenorhabditis elegans is confined to intestinal cells. EMBO J. 12 (1993) 1615-1620
39. Lincke C.R., The I., van Groenigen M., and Borst P. The P-glycoprotein gene family of Caenorhabditis elegans: cloning and characterization of genomic and complementary DNA sequences. J. Mol. Biol. 228 (1992) 701-711
40. -ΔΔCT method. Methods 25 (2001) 402-408
41. Martins M.J., Negrao M.R., and Hipolito-Reis C. Alkaline phosphatase from rat liver and kidney is differentially modulated. Clin. Biochem. 34 (2001) 463-468
42. Marzolini C., Paus E., Buclin T., and Kim R.B. Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin. Pharmacol. Ther. 75 (2004) 13-33
43. Merino G., Alvarez A.I., Prieto J.G., and Kim R.B. The anthelmintic agent albendazole does not interact with P-glycoprotein. Drug Metab. Dispos. 30 (2002) 365-369
44. Naito S., Koike K., Ono M., Machida T., Tasaka S., Kiue A., Koga H., and Kumazawa J. Development of novel reversal agents, imidothiazole derivatives, targeting MDR1- and MRP-mediated multidrug resistance. Oncol. Res. 10 (1998) 123-132
45. Nare B., Liu Z., Prichard R.K., and Georges E. Benzimidazoles, potent anti-mitotic drugs: Substrates for the P-glycoprotein transporter in multidrug-resistant cells. Biochem. Pharmacol. 48 (1994) 2215-2222
46. Novak J., and Vanek Z. Screening for a new generation of anthelminthic compounds. In vitro selection of the nematode Caenorhabditis elegans for ivermectin resistance. Folia. Microbiol. (Praha) 37 (1992) 237-238
47. Perez-Victoria J.M., Parodi-Talice A., Torres C., Gamarro F., and Castanys S. ABC transporters in the protozoan parasite Leishmania. Int. Microbiol. 4 (2001) 159-166
48. Prichard R. Genetic variability following selection of Haemonchus contortus with anthelmintics. Trends Parasitol. 17 (2001) 445-453
49. Rothwell J., and Sangster N. Haemonchus contortus: the uptake and metabolism of closantel. Int. J. Parasitol. 27 (1997) 313-319
50. Sangster N.C. P-glycoproteins in nematodes. Parasitol. Today 10 (1994) 310-322
51. Sangster N.C. Anthelmintic resistance: past, present and future. Int. J. Parasitol. 29 (1999) 115-124
52. Simpkin K.G., and Coles G.C. The use of Caenorhabditis elegans for anthelmintic screening. J. Chem. Tech. Biotechnol. 31 (1981) 66-69
53. Suzukake K., Petro B.J., and Vistica D.T. Reduction in glutathione content of l-PAM resistant L1210 cells confers drug sensitivity. Biochem. Pharmacol. 31 (1982) 121-124
54. Tew K.D. Redox in redux: emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signalling and S-glutathionylation. Biochem. Pharm. 73 (2007) 1257-1269
55. van Wyk J.A., and Malan F.S. Resistance of field strains of Haemonchus contortus to ivermectin, closantel, rafoxanide and the benzimidazoles in South Africa. Vet. Rec. 123 (1988) 226-228
56. Waller P.J. International approaches to the concept of integrated control of parasites of livestock. Int. J. Parasitol. 29 (1999) 155-164
57. Xu M., Molento M., Blackhall W.J., Ribeiro P., Beech R.N., and Prichard R.K. Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog. Mol. Biochem. Parasitol. 91 (1998) 327-335
58. Yabe T., Suzuki N., Furukawa T., and Ishihara Katsura I. Multidrug resistance-associated protein MRP-1 regulates dauer dispause by its export activity in Caenorhabditis elegans. Development 132 (2005) 3197-07